IceCure Medical Ltd. filed a Report of Foreign Private Issuer on November 19, 2026, disclosing that shareholders approved a proposal at a Special General Meeting held the same day after the meeting was initially adjourned for lack of quorum.
Key Highlights
- Meeting adjourned then reconvened: The Special General Meeting originally scheduled for 10:00 a.m. (Israel time) lacked the required quorum and was adjourned, then reconvened at 11:30 a.m. (Israel time).
- Proposal approved: At the reconvened meeting, a quorum was present and shareholders approved the proposal described in the company's proxy statement for the meeting.
- Proxy statement reference: The proxy statement was included as Exhibit 99.2 to a Report of Foreign Private Issuer furnished to the SEC on November 2, 2026.
- Registration statement incorporation: The filing is incorporated by reference into multiple Form F-3 and Form S-8 registration statements filed with the SEC, as identified by specific file numbers in the report.
- Signed by CEO: The report was signed by Eyal Shamir, Chief Executive Officer of IceCure Medical Ltd., on November 19, 2026.
IceCure Medical Special General Meeting: Quorum, Adjournment, and Shareholder Vote
IceCure Medical Ltd., an Israel-based medical device company listed on NASDAQ:ICCM, convened a Special General Meeting of Shareholders on November 19, 2026, according to the filing. The meeting was initially called to order at 10:00 a.m. (Israel time) but could not proceed, as the filing states it "was initially adjourned due to the absence of the required quorum present to open and conduct it at the initial time."
The meeting was subsequently reconvened at 11:30 a.m. (Israel time) on the same day. According to the filing, once reconvened, a quorum was present and "Company's shareholders approved the proposal described in the Company's proxy statement for the Meeting." That proxy statement had been furnished to the SEC on November 2, 2026, as Exhibit 99.2 to a prior Report of Foreign Private Issuer. The filing does not describe the specific content of the approved proposal beyond this reference.
The company disclosed that this report is incorporated by reference into its Registration Statements on Form F-3, bearing file numbers 333-297030, 333-290046, and 333-258660, as well as on Form S-8, bearing file numbers 333-298361, 333-270982, 333-264578, 333-262620, and 333-281587. The filing specifies that the incorporation applies "to the extent not superseded by documents or reports subsequently filed or furnished." IceCure Medical Ltd. is a foreign private issuer that files annual reports under Form 20-F, as indicated on the cover page of the report.
What Was Disclosed
IceCure Medical Ltd. reported that its Special General Meeting of Shareholders on November 19, 2026, was adjourned for lack of quorum, then reconvened, at which point shareholders approved the proposal set out in the company's November 2, 2026 proxy statement.



Please wait processing your request...